Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Teva quits brand lobby PhRMA, in line to lead generic lobby AAM

  • John Wilkerson

By John Wilkerson Feb. 2, 2023

Reprints
Teva building
Adobe

WASHINGTON  — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has learned.  

“Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell confirmed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

John Wilkerson

John Wilkerson

Washington Correspondent

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care.

Tags

Create a display name to comment

This name will appear with your comment

The health care industry’s lax approach to nurses’ mental…
The health care industry’s lax approach to nurses’ mental health needs to change
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
California judge deals GSK a setback as first Zantac…
California judge deals GSK a setback as first Zantac lawsuit will now go to trial
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug

Recommended Stories